Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
2.200
+0.140 (6.80%)
Feb 24, 2026, 4:00 PM EST - Market closed
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $3.06 million as of February 25, 2026. Its market cap has decreased by -4.54% in one year.
Market Cap
3.06M
Enterprise Value
-698.86K
1-Year Change
-4.54%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $3.06M, a decrease of -100.00%. That is a compound annual growth rate of -87.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 2.86M | -22.90% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HCW Biologics | 3.34M |
| Propanc Biopharma | 3.04M |
| Dermata Therapeutics | 3.03M |
| Oragenics | 2.70M |
| SciSparc | 2.68M |
| Adial Pharmaceuticals | 2.67M |
| Psyence Biomedical | 2.60M |
| XORTX Therapeutics | 2.59M |